MMM. K. Melnikova

M. K. Melnikova

*This is an algorithmically generated author record based on publicly available information.

M. K. Melnikova has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Artem V. Kartashev

    A.M. Granov Russian Research Center of Radiology and Surgical Technologies

    1 shared publication
  • Juliya Nikolaevna Vinogradova

    Russian Scientific Centre of Radiology and Surgical Technologies named after Academician A.M. Granov of the Ministry of Health of Russia

    1 shared publication
  • А. В. Карташев

    Российский научный центр радиологии и хирургическихтехнологий имени академика А.М. Гранова Минздрава России

    1 shared publication
  • М. В. Артемов

    Российский научный центр радиологии и хирургическихтехнологий имени академика А.М. Гранова Минздрава России

    1 shared publication
  • М. К. Мельникова

    Российский научный центр радиологии и хирургическихтехнологий имени академика А.М. Гранова Минздрава России

    1 shared publication
  • Максим Владимирович Артемов

    A.M. Granov Russian Research Center of Radiology and Surgical Technologies

    1 shared publication

Latest Publications

  • Open Access

    Diagnostic Significance of MRI in the Assessment of Meningiomas after Stereotactic Radiosurgery: Morphological Features and Dynamics of Changes

    by M. K. Melnikova, M. V. Artemov, Y. N. Vinogradova, A. V. Kartashev, М. К. Мельникова, М. В. Артемов, Ю. Н. Виноградова, А. В. Карташев

    Purpose : To improve the efficiency of diagnostic monitoring of patients with meningiomas after stereotactic radiosurgery. Materials and methods : This retrospective, single-center study included 50 patients with meningiomas who underwent stereotactic radiosurgery (SRS) using the Gamma Knife ICON (Elekta). The mean age was 64.9 ± 11.6 years. Skull base meningiomas were detected in 21 of 50 patients (42.0 %), parasagittal meningiomas in 18 of 50 (36.0 %), and convexital meningiomas in 11 of 50 (22.0 %). Histological verification (based on the results of the previous resection) was performed in 24 patients: Grade I — 10, Grade II — 8, Grade III — 6. Follow-up MRI examinations were performed 3, 6, and 12–14 months after SRS. For each tumor, changes in area (using the RANO criteria) and volume were determined; agreement between the methods was assessed using the Cohen’s kappa coefficient. In addition, qualitative MRI features were assessed: contrast enhancement pattern, perifocal edema, margin clarity, and the presence of new lesions. Results : According to the volume classification, progression was observed in 12 of 50 patients (24.0 %; 95 % CI: 14.3–37.4), stabilization in 32 of 50 (64.0 %), and response in 6 of 50 (12.0 %). According to the RANO criteria: 10 of 50 (20.0 %) / 21 of 50 (42.0 %) / 19 of 50 (38.0 %), respectively. The agreement between the two methods was 68.0 % (Cohen’s kappa 0.498). The grade of malignancy was significantly associated with progression (chi-square p = 0.043; pairwise Grade I vs III: p = 0.035); localization was not (p = 0.84). A combination of qualitative MR features demonstrated high diagnostic efficacy: persistent heterogeneous contrast enhancement at 12-14 months, combined with pathological dynamics of perifocal changes. Each feature was characterized by a different sensitivityspecificity ratio: the appearance of new lesions — Sn 41.7 %, Sp 100 %; perifocal edema — Sn 41.7 %, Sp 92.1 %; the appearance of fuzzy margins — Sn 25.0 %, Sp 100 %. Conclusion : Quantitative volumetric assessment of meningiomas after SRS proved more sensitive compared to area-based assessment (RANO), additionally identifying cases of occult progression in 2 patients (4 %). The grade of meningioma malignancy is a significant factor associated with the risk of progression; a significant difference was found between Grade I and Grade III. The location of the lesion did not affect treatment outcomes. A set of qualitative MRI features (characteristics and dynamics of contrast enhancement, perifocal edema, clarity of contours, new lesions) provides the basis for differential diagnosis of true progression and post-radiation reactions.